Back to Browse Journals » Clinical Interventions in Aging » Volume 5

Review of topiramate for the treatment of epilepsy in elderly patients

Authors BR Sommer, HH Fenn

Published Date April 2010 Volume 2010:5 Pages 89—99

DOI http://dx.doi.org/10.2147/CIA.S3785

Published 7 April 2010

BR Sommer1, HH Fenn2

1Department of Psychiatry, Stanford University School of Medicine, Stanford, California USA; 2Palo Alto VA Healthcare System, Acute Geropsychiatry Unit, Menlo Park Division, Menlo Park, California, USA

Abstract: Individuals over 65 years of age experience the new onset of seizures at a prevalence rate of roughly twice that of younger adults. Differences in physiology, need of concomitant medications, and liability for cognitive deficits in this population, make the choice of anticonvulsant drugs especially important. This paper reviews topiramate (TPM), a treatment for many types of seizures, with the above risks in mind. In particular, we discuss efficacy and pharmacokinetics with emphasis on the older patient, and adverse events in both the younger and older adult. With most studies of TPM-induced cognitive deficits having been performed in younger adults and volunteers, we discuss the implications for the older adult. Even in studies of younger individuals, up to 50% discontinue TPM because of intolerable cognitive deficits. Most studies find specific declines in working memory and verbal fluency. In conclusion, we give recommendations for use of this antiepileptic drug in this population.
Keywords: topiramate, elderly, epilepsy, treatment, cognition, pharmacokinetics

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene

Luigi Gennari, Daniela Merlotti, Ranuccio Nuti

Clinical Interventions in Aging 2010, 5:19-29

Published Date: 28 January 2010

Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives

M Kernt, A Kampik

Clinical Ophthalmology 2010, 4:121-135

Published Date: 5 March 2010

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction

Christine Benn Christiansen, Christian Torp-Pedersen, Lars Køber

Clinical Interventions in Aging 2010, 5:63-69

Published Date: 29 March 2010

Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures

Alberto Goldman, Uwe Wollina

Clinical Interventions in Aging 2010, 5:293-299

Published Date: 14 September 2010

Elderly quality of life impacted by traditional chinese medicine techniques

Helena A Figueira, Olivia A Figueira, Alan A Figueira, et al

Clinical Interventions in Aging 2010, 5:301-305

Published Date: 1 October 2010

Physician contact by older Asian Americans: the effects of perceived mental health need

Duy Nguyen

Clinical Interventions in Aging 2010, 5:333-336

Published Date: 16 November 2010

Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation

Castagna A, Rinaldi S, Fontani V, Mannu P, Lotti Margotti M

Clinical Interventions in Aging 2011, 6:201-206

Published Date: 25 July 2011

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease

Mannu P, Rinaldi S, Fontani V, Castagna A

Clinical Interventions in Aging 2011, 6:207-211

Published Date: 26 July 2011